Nanocellect biomedical INC., to identify actionable molecular pathways of acute rejection treatment failure in lung transplants.

Ended Purchase Order Awarded

Contract number
75N92021P00186
Awardee
Awarding agency
Obligated
$95,120

Award facts

Contract value 100% obligated
$95,120.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325414 Biological Product (except Diagnostic) Manufacturing
PSC
6640 Laboratory Equipment And Supplies
Set-aside
No set-aside
Competition
Not Competed · 1 offer Only One Source
Pricing
Firm Fixed Price
Place of performance
San Diego, CA 92122, USA

Award details come from SAM.gov/FPDS.

About this award

Nanocellect Biomedical Inc. has been awarded a $95,120 firm fixed price purchase order by the National Heart, Lung and Blood Institute of the National Institutes of Health within the Department of Health and Human Services. Under this contract, Nanocellect Biomedical will identify actionable molecular pathways of acute rejection treatment failure in lung transplants to support the Institute's research efforts to improve outcomes for lung transplant patients. Performance will occur in San Diego, California over a three-month period concluding in early September 2021. No set aside designation or subcontracting details were provided.

Quick answers

Who was awarded contract 75N92021P00186?

75N92021P00186 was awarded to Nanocellect Biomedical Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on June 7, 2021.

How much is contract 75N92021P00186 worth?

The government has obligated $95,120 on 75N92021P00186.

Was contract 75N92021P00186 competed?

The extent of competition for 75N92021P00186 was not competed. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award